Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Post Herpetic Neuralgia Drugs Market Insights, Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Post Herpetic Neuralgia Drugs Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Post Herpetic Neuralgia Drugs Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Post Herpetic Neuralgia Drugs Market Size Growth Rate by Type
    • 1.4.2 Anticonvulsants
    • 1.4.3 Antidepressants
    • 1.4.4 Opioids
    • 1.4.5 Others
  • 1.5 Market by Application
    • 1.5.1 Global Post Herpetic Neuralgia Drugs Market Size Growth Rate by Application
    • 1.5.2 Hospital Pharmacies
    • 1.5.3 Online Pharmacies
    • 1.5.4 Retail Pharmacies
  • 1.6 Coronavirus Disease 2019 (Covid-19): Post Herpetic Neuralgia Drugs Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Post Herpetic Neuralgia Drugs Industry
      • 1.6.1.1 Post Herpetic Neuralgia Drugs Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Post Herpetic Neuralgia Drugs Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Post Herpetic Neuralgia Drugs Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Post Herpetic Neuralgia Drugs Market Size Estimates and Forecasts
    • 2.1.1 Global Post Herpetic Neuralgia Drugs Revenue 2015-2026
    • 2.1.2 Global Post Herpetic Neuralgia Drugs Sales 2015-2026
  • 2.2 Post Herpetic Neuralgia Drugs Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Post Herpetic Neuralgia Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Post Herpetic Neuralgia Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Post Herpetic Neuralgia Drugs Competitor Landscape by Players

  • 3.1 Post Herpetic Neuralgia Drugs Sales by Manufacturers
    • 3.1.1 Post Herpetic Neuralgia Drugs Sales by Manufacturers (2015-2020)
    • 3.1.2 Post Herpetic Neuralgia Drugs Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Post Herpetic Neuralgia Drugs Revenue by Manufacturers
    • 3.2.1 Post Herpetic Neuralgia Drugs Revenue by Manufacturers (2015-2020)
    • 3.2.2 Post Herpetic Neuralgia Drugs Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Post Herpetic Neuralgia Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Post Herpetic Neuralgia Drugs Revenue in 2019
    • 3.2.5 Global Post Herpetic Neuralgia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Post Herpetic Neuralgia Drugs Price by Manufacturers
  • 3.4 Post Herpetic Neuralgia Drugs Manufacturing Base Distribution, Product Types
    • 3.4.1 Post Herpetic Neuralgia Drugs Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Post Herpetic Neuralgia Drugs Product Type
    • 3.4.3 Date of International Manufacturers Enter into Post Herpetic Neuralgia Drugs Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Post Herpetic Neuralgia Drugs Market Size by Type (2015-2020)
    • 4.1.1 Global Post Herpetic Neuralgia Drugs Sales by Type (2015-2020)
    • 4.1.2 Global Post Herpetic Neuralgia Drugs Revenue by Type (2015-2020)
    • 4.1.3 Post Herpetic Neuralgia Drugs Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Post Herpetic Neuralgia Drugs Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Post Herpetic Neuralgia Drugs Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Post Herpetic Neuralgia Drugs Revenue Forecast by Type (2021-2026)
    • 4.2.3 Post Herpetic Neuralgia Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Post Herpetic Neuralgia Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Post Herpetic Neuralgia Drugs Market Size by Application (2015-2020)
    • 5.1.1 Global Post Herpetic Neuralgia Drugs Sales by Application (2015-2020)
    • 5.1.2 Global Post Herpetic Neuralgia Drugs Revenue by Application (2015-2020)
    • 5.1.3 Post Herpetic Neuralgia Drugs Price by Application (2015-2020)
  • 5.2 Post Herpetic Neuralgia Drugs Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Post Herpetic Neuralgia Drugs Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Post Herpetic Neuralgia Drugs Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Post Herpetic Neuralgia Drugs Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Post Herpetic Neuralgia Drugs by Country
    • 6.1.1 North America Post Herpetic Neuralgia Drugs Sales by Country
    • 6.1.2 North America Post Herpetic Neuralgia Drugs Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Post Herpetic Neuralgia Drugs Market Facts & Figures by Type
  • 6.3 North America Post Herpetic Neuralgia Drugs Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Post Herpetic Neuralgia Drugs by Country
    • 7.1.1 Europe Post Herpetic Neuralgia Drugs Sales by Country
    • 7.1.2 Europe Post Herpetic Neuralgia Drugs Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Post Herpetic Neuralgia Drugs Market Facts & Figures by Type
  • 7.3 Europe Post Herpetic Neuralgia Drugs Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Post Herpetic Neuralgia Drugs by Region
    • 8.1.1 Asia Pacific Post Herpetic Neuralgia Drugs Sales by Region
    • 8.1.2 Asia Pacific Post Herpetic Neuralgia Drugs Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Post Herpetic Neuralgia Drugs Market Facts & Figures by Type
  • 8.3 Asia Pacific Post Herpetic Neuralgia Drugs Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Post Herpetic Neuralgia Drugs by Country
    • 9.1.1 Latin America Post Herpetic Neuralgia Drugs Sales by Country
    • 9.1.2 Latin America Post Herpetic Neuralgia Drugs Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Post Herpetic Neuralgia Drugs Market Facts & Figures by Type
  • 9.3 Central & South America Post Herpetic Neuralgia Drugs Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Post Herpetic Neuralgia Drugs by Country
    • 10.1.1 Middle East and Africa Post Herpetic Neuralgia Drugs Sales by Country
    • 10.1.2 Middle East and Africa Post Herpetic Neuralgia Drugs Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Post Herpetic Neuralgia Drugs Market Facts & Figures by Type
  • 10.3 Middle East and Africa Post Herpetic Neuralgia Drugs Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Depomed
    • 11.1.1 Depomed Corporation Information
    • 11.1.2 Depomed Description, Business Overview and Total Revenue
    • 11.1.3 Depomed Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Depomed Post Herpetic Neuralgia Drugs Products Offered
    • 11.1.5 Depomed Recent Development
  • 11.2 Pfizer
    • 11.2.1 Pfizer Corporation Information
    • 11.2.2 Pfizer Description, Business Overview and Total Revenue
    • 11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Pfizer Post Herpetic Neuralgia Drugs Products Offered
    • 11.2.5 Pfizer Recent Development
  • 11.3 Daiichi Sankyo
    • 11.3.1 Daiichi Sankyo Corporation Information
    • 11.3.2 Daiichi Sankyo Description, Business Overview and Total Revenue
    • 11.3.3 Daiichi Sankyo Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Daiichi Sankyo Post Herpetic Neuralgia Drugs Products Offered
    • 11.3.5 Daiichi Sankyo Recent Development
  • 11.1 Depomed
    • 11.1.1 Depomed Corporation Information
    • 11.1.2 Depomed Description, Business Overview and Total Revenue
    • 11.1.3 Depomed Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Depomed Post Herpetic Neuralgia Drugs Products Offered
    • 11.1.5 Depomed Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Post Herpetic Neuralgia Drugs Market Estimates and Projections by Region
    • 12.1.1 Global Post Herpetic Neuralgia Drugs Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Post Herpetic Neuralgia Drugs Revenue Forecast by Regions 2021-2026
  • 12.2 North America Post Herpetic Neuralgia Drugs Market Size Forecast (2021-2026)
    • 12.2.1 North America: Post Herpetic Neuralgia Drugs Sales Forecast (2021-2026)
    • 12.2.2 North America: Post Herpetic Neuralgia Drugs Revenue Forecast (2021-2026)
    • 12.2.3 North America: Post Herpetic Neuralgia Drugs Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Post Herpetic Neuralgia Drugs Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Post Herpetic Neuralgia Drugs Sales Forecast (2021-2026)
    • 12.3.2 Europe: Post Herpetic Neuralgia Drugs Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Post Herpetic Neuralgia Drugs Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Post Herpetic Neuralgia Drugs Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Post Herpetic Neuralgia Drugs Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Post Herpetic Neuralgia Drugs Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Post Herpetic Neuralgia Drugs Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Post Herpetic Neuralgia Drugs Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Post Herpetic Neuralgia Drugs Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Post Herpetic Neuralgia Drugs Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Post Herpetic Neuralgia Drugs Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Post Herpetic Neuralgia Drugs Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Post Herpetic Neuralgia Drugs Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Post Herpetic Neuralgia Drugs Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Post Herpetic Neuralgia Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Post Herpetic Neuralgia Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Post Herpetic Neuralgia Drugs Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for postherpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.
    Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Post Herpetic Neuralgia Drugs market in 2020.
    COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
    The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
    This report also analyses the impact of Coronavirus COVID-19 on the Post Herpetic Neuralgia Drugs industry.
    Based on our recent survey, we have several different scenarios about the Post Herpetic Neuralgia Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Post Herpetic Neuralgia Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
    With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Post Herpetic Neuralgia Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Post Herpetic Neuralgia Drugs market in terms of both revenue and volume.
    Players, stakeholders, and other participants in the global Post Herpetic Neuralgia Drugs market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
    Sales and Pricing Analyses
    Readers are provided with deeper sales analysis and pricing analysis for the global Post Herpetic Neuralgia Drugs market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
    In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
    Regional and Country-level Analysis
    The report offers an exhaustive geographical analysis of the global Post Herpetic Neuralgia Drugs market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
    Competition Analysis
    In the competitive analysis section of the report, leading as well as prominent players of the global Post Herpetic Neuralgia Drugs market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Post Herpetic Neuralgia Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Post Herpetic Neuralgia Drugs market.
    The following manufacturers are covered in this report:
    Depomed
    Pfizer
    Daiichi Sankyo
    ...
    Post Herpetic Neuralgia Drugs Breakdown Data by Type
    Anticonvulsants
    Antidepressants
    Opioids
    Others
    Post Herpetic Neuralgia Drugs Breakdown Data by Application
    Hospital Pharmacies
    Online Pharmacies
    Retail Pharmacies

    Buy now